R&D budgets in perspective
Posted in Tips
A sense of scale can be valuable. Here are the 2012 Research & Development budgets of several tech companies and pharmaceutical companies compared to approximate annual disbursements from the Wellcome Trust and the HHMI. I’ve also included the annual budgets of the NIH, NSF, and DOD as well. All numbers are for 2012, or as close as I could get. If any of the numbers seem off, let me know. They’re all from public sources (SEC filings, annual reports, etc.).
Note that combined R&D budgets of six Big Pharma companies exceeds that of the NIH.
It’s also interesting to look at how the NIH budget breaks down per institute:
Some additions from Europe: 2012 figures
ERC = 2.1 billion USD
MRC = Less than 1 billion USD
One more comparison:
The 2012 presidential and congressional elections = 5.8 billion USD.
http://www.opensecrets.org/bigpicture/
Do your sources separate research from development budgets within the pharmaceutical companies? I’d be interested to see what the split looks like.
Thanks!
Nope.
SEC filings just give the total R&D budget. If anyone knows how this might break down, let me know!
[…] Previously… Sense of scale R&D budgets in perspective […]
Canadian Institutes of Health Research invests approximately CAN$1 billion each year. That’s about US$750k.
Sorry that should of course have been US$750M